Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Oncopeptides AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 36,772 Less Arrow 7,903 More Arrow 115,364
Financial expenses 5,860 Less Arrow 835 More Arrow 925
Earnings before taxes -251,685 Less Arrow -319,416 Less Arrow -1,386,154
EBITDA -245,566 Less Arrow -314,202 Less Arrow -1,364,870
Total assets 241,484 More Arrow 364,482 More Arrow 428,490
Current assets 205,544 More Arrow 344,344 More Arrow 402,155
Current liabilities 45,519 More Arrow 78,679 More Arrow 219,664
Equity capital 57,520 More Arrow 278,375 Less Arrow 205,643
- share capital 10,648 Less Arrow 9,912 Less Arrow 8,159
Employees (average) 52 More Arrow 57 More Arrow 229

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 23.8% More Arrow 76.4% Less Arrow 48.0%
Turnover per employee 707 Less Arrow 139 More Arrow 504
Profit as a percentage of turnover -684.4% Less Arrow -4041.7% More Arrow -1201.5%
Return on assets (ROA) -101.8% More Arrow -87.4% Less Arrow -323.3%
Current ratio 451.6% Less Arrow 437.7% Less Arrow 183.1%
Return on equity (ROE) -437.6% More Arrow -114.7% Less Arrow -674.1%
Change turnover 28,308 Less Arrow -103,994 More Arrow 115,364
Change turnover % 334% Less Arrow -93%
Chg. No. of employees -5 Less Arrow -172 More Arrow 47
Chg. No. of employees % -9% Less Arrow -75% More Arrow 26%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.